期刊
BIOMARKERS
卷 16, 期 4, 页码 289-301出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/1354750X.2011.561366
关键词
Connective tissue growth factor; fibrosis; biomarker; sandwich ELISA
资金
- FibroGen Inc.
- San Francisco, CA, USA
Background: Connective tissue growth factor (CTGF) has been identified as a key factor in the pathogenesis of diseases with significant fibrosis-related complications such as hepatitis, diabetes and renal transplantation. Increasing evidence shows that CTGF levels in plasma, serum and urine have promising biomarker applicability in these disorders. Objective: To present an overview of current knowledge on CTGF in various patient populations and the technical aspects of CTGF measurement by enzyme-linked immunosorbent assay (ELISA). Method: We performed a comprehensive literature search by using electronic bibliographic databases. Conclusion: CTGF is associated with disease severity parameters and outcome in fibrotic disease and may have diagnostic and prognostic values. However, CTGF ELISA needs standardization.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据